SEC Form 4 · accession 0001225208-16-041123
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael F Mahoney
Officer — President & CEO · Director
Period of report
Nov 1, 2016
Accepted (ET)
Nov 3, 2016 · 4:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 22, 2016 | G | 52,000 | $0.00 | D | 1,336,177 | D | |
| Common StockF1 | Nov 1, 2016 | M | 341,670 | $0.00 | A | 1,677,847 | D | |
| Common Stock | Nov 1, 2016 | F | 160,756 | $21.71 | D | 1,517,091 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Stock UnitsF1,F2 | $0.00 | Nov 1, 2016 | M | 341,670 | D | — | — | Common Stock | 341,670 | 0 | D |
Explanation of responses
- F1Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- F2Shares of common stock will be issued to the reporting person in five equal annual installments beginning on November 1, 2012, the first anniversary of the date of grant.